Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market.
Eli Lilly and Company announced earlier this week that its popular obesity drug, Zepbound (tirzepatide) outperformed rival ...
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products.
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.
BioAge Labs said on Friday it is discontinuing the mid-stage trial of its experimental obesity drug after high levels of ...
Jessica Shepherd, M.D., chief medical officer of hers, joins ABC News Live to discuss the effects of hospitals closing their ...
The foreign ministry of Russia, a longtime ally, did not provide details on where President Bashar al-Assad had gone. Rebels stormed the Syrian capital on Sunday without encountering any ...